The Neurodevelopmental and Behavioral Phenotyping Screening Protocol
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00271622|
Recruitment Status : Recruiting
First Posted : January 2, 2006
Last Update Posted : October 19, 2020
|Condition or disease|
|Neurologic Disorders Autism Neurodegenerative Disease Neurobehavioral Manifestation|
|Study Type :||Observational|
|Estimated Enrollment :||5000 participants|
|Official Title:||The Neurodevelopmental and Behavioral Phenotyping Screening Protocol|
|Actual Study Start Date :||February 27, 2006|
individuals with risk for psychiatric disorders or neurodevelo
individuals with risk for psychiatric disorders or neurodevelopmental disorders, such as autism spectrum disorders.
- Screening evaluations such as a psychiatric interview; a diagnostic interview; developmental and/or cognitive testing; ratings of other psychiatric symptoms [ Time Frame: ongoing ]This is a screening protocol and screening evaluations such as apsychiatric interview; a diagnostic interview; developmental and/or cognitive testing; ratings of other psychiatric symptoms are conducted.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00271622
|Contact: Audrey E Thurm, Ph.D.||(301) firstname.lastname@example.org|
|United States, Maryland|
|National Institutes of Health Clinical Center, 9000 Rockville Pike||Recruiting|
|Bethesda, Maryland, United States, 20892|
|Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 email@example.com|
|Principal Investigator:||Audrey E Thurm, Ph.D.||National Institute of Mental Health (NIMH)|